Drive innovation with more predictable results.
We have more information than ever before about multiple sclerosis, Parkinson's disease, stroke, Alzheimer’s disease, and other neurological disorders. IQVIA helps you drill down and turn data into indication-specific insights.
Globally … neurological disorders were the leading cause of disability-adjusted life years and second leading cause of deaths.
Source: LANCET NEUROL.
2019 May;18(5):459-480
Innovate at the speed of analytics
The demand for a new discipline
Break through CNS challenges with the IQVIA CORE™
As one of the highest areas of unmet needs, central nervous system (CNS) diseases are diverse, occurring at different life stages and different severities. With fewer early stage trials and a high attrition rate, CNS development presents a higher level of risk. By integrating unparalleled data, advanced analytics and fit-for-purpose machine learning, IQVIA provides innovative approaches to help you manage risk and find the right path to success.
From research through commercialization, it's all powered by the IQVIA CORE, a holistic approach that integrates our resources to meet your needs.
IQVIA is using vast quantities of data in powerful new ways. See how we can help you tap into information from past trials, patient reported outcomes and other sources to accelerate your research.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Tap into evidence networks in oncology, neurology, immunology, and other therapy areas to enrich your studies.